3rd Quarter - Termination
XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Aug 21, 2015
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 6 "The 21st Century Cures Act," all provisions pertaining to patient access to treatments and orphan drug incentives. Senate draft legislation currently titled "Innovation for Healthier Americans," all provisions pertaining to orphan drug incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.